Within the FDA, the Center for Drug Evaluation and Research, or CDER, is responsible for monitoring the development, production, and labeling of drugs, and some biologics, to ensure their safety and efficacy. CDER relies on the results of clinical trials to review the benefits and possible harms associated with new treatments. Regulators at CDER are also committed to making promising new treatments available to patients as efficiently as possible, a goal that is achieved through the use of expedited mechanisms.